BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Europe currently has over 100 early and managed access\, compa
 ssionate use\, and named patient programmes running across the continent.
  However\, the multi-layered regulatory frameworks that require both EMA 
 and country-specific legislation mean that getting pre-approved drugs to 
 European patients is fraught with operational challenges.\n\nOn the back 
 of several years of successfully running the US Operationalize: Expanded 
 Access Programs Summit\, we are extremely excited to bring you the Europe
 an version this October!\n\nThe inaugural Operationalise: Early Access Pr
 ogrammes Summit Europe is the response to the industry’s plea for a great
 er understanding and clarity regarding the end-to-end management of runni
 ng a European early access programme. With each and every speaker sharing
  the same desire to increase the success\, ease and treatment options for
  patients in need\, ensure that you are part of this timely conversation.
 \n\nThis is your only opportunity to learn from large pharma\, leading bi
 otech’s and patient advocates on key topics such as:\n\nEnsure smooth EAP
  regulatory navigation with Novartis\, Gensight and GSK as they share key
  lessons from French\, British\, German and emerging markets\n\nOrganise 
 supply and anticipate demand across multiple borders in accordance with p
 roduct and country specific requirements with GSK\, Teva and BeiGene\n\nO
 utline methods to reduce barriers for early access programmes with EURORD
 IS\, Ataxia &amp\; Me and TheSocialMedwork to support more patient popula
 tionsDistinguish an exit strategy to end an early access programme and mo
 ve to commercialisation with Merck Group\n\nOptimise data collection and 
 real-world data generation regulations in Europe with Secura Bio\n\nAs th
 e demand for compassionate use\, early\, and managed access programmes be
 comes an ever-expected avenue for drug acquisition\, join us to further y
 our understanding of how to set up\, operationalise\, communicate\, deliv
 er and close out your altruistic programme without running into regulator
 y\, financial or distributional challenges.\n\nBy uniting Europe’s leadin
 g Early Access Programme thinkers\, this exclusive platform will clarify 
 the complex issues through end-to-end Named Patient and Compassionate Use
  programme operationalisation. Through open discussion\, sharing best-pra
 ctice case studies\, and removing hypotheticals\, this meeting will provi
 de an unrivalled opportunity to solve your challenges across the entire t
 imeline such as navigating European regulations\, product labelling requi
 rements and closing an early access programme.\n\nWhether you’re a vetera
 n at managing early access programmes and are looking to expand your geo\
 , or a new entrant to the field\, you’ll leave this conference with the p
 ractical lessons and essential connections needed to supercharge your Eur
 opean early access programme across 2022 and beyond.\n
DTEND:20221020T170000
DTSTAMP:20260512T232257Z
DTSTART:20221018T100000
LOCATION:Hilton London Kensington\, 179-199 Holland Park Avenue\, London\,
  England\, W11 4UL\,
SEQUENCE:0
SUMMARY:Europe currently has over 100 early and managed access\, compassio
 nate use\, and named patient programmes running across the continent. How
 ever\, the...
UID:92bdf5d0-d347-4311-bb18-f2af4e1a2de2
END:VEVENT
END:VCALENDAR
